Assignee
HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD
CN·3 granted patents·4 pending applications·3 citations·filing 2017–2025
Top patents by PatentIndex Score
7 records- 0178USRE49834EJak1 selective inhibitors and uses thereofHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2017·Granted Feb 13, 2024·1 cites·22 claims
- 0277US12297206B2Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of saltHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2020·Granted May 13, 2025·1 cites·3 claims
- 0374US12195476B2Synthesis method of furoimidazopyridine compound, crystal form of furoimidazopyridine compound, and crystal form of salt thereofHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2020·Granted Jan 14, 2025·1 cites·27 claims
- 0460US2025263420A1Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of saltHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0557US2025032465A1Methods of treating cns disordersHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0653US2025206742A1Nlrp3 inflammasome inhibitorsHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0752US2025171458A1Method for synthesizing 1h-furo[3,2-b]imidazo[4,5-d]pyridine compoundHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →